GlassScriptPhysician profile
Saumeel Mehta
NPI 1033244645
$1,366.10
in general payments reported to CMS, 2019-2025
15 companies · $371 in 2025
The $371 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.60 · 2020: $84.57 · 2021: $88.45 · 2022: $277 · 2023: $281 · 2024: $177 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $191.84 | 2020-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Pfizer INC. | $180.31 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $153.23 | 2024-2025 | |
| Cranial Technologies, INC | $136.66 | 2019-2023 | Doc Band |
| Bayer Healthcare Pharmaceuticals INC. | $114.75 | 2025 | |
| Xeris Pharmaceuticals, INC. | $111.86 | 2022 | |
| Glaxosmithkline, LLC. | $107.38 | 2020-2024 | Pediarix, Bexsero, Rotarix |
| Astrazeneca Pharmaceuticals LP | $83.16 | 2025 | Airsupra |
| Abbvie INC. | $73.47 | 2022 | |
| Exact Sciences Corporation | $72.35 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $67.46 | 2022-2024 | Immunocap |
| Verrica Pharmaceuticals INC. | $24.55 | 2023 | Ycanth |
| Ironshore Pharmaceuticals INC. | $24.17 | 2024 | |
| Sanofi Pasteur INC. | $13.92 | 2021 | |
| Medexus Pharma, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saumeel Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.